ExcelMale
Menu
Home
What's new
Latest activity
Forums
New posts
Search forums
What's new
New posts
Latest activity
Videos
Lab Tests
Doctor Finder
Buy Books
About Us
Men’s Health Coaching
Log in
Register
What's new
Search
Search
Search titles only
By:
New posts
Search forums
Menu
Log in
Register
Navigation
Install the app
Install
More options
Contact us
Close Menu
Forums
Testosterone Replacement, Low T, HCG, & Beyond
Prostate Related Issues
How High Testosterone Doses Are Helping Men with Prostate Cancer
JavaScript is disabled. For a better experience, please enable JavaScript in your browser before proceeding.
You are using an out of date browser. It may not display this or other websites correctly.
You should upgrade or use an
alternative browser
.
Reply to thread
Message
<blockquote data-quote="Nelson Vergel" data-source="post: 199145" data-attributes="member: 3"><p><strong>Reversing the effects of androgen deprivation therapy in men with metastatic castration resistant prostate cancer</strong></p><p></p><p>Abstract</p><p>Background: Bipolar androgen therapy (BAT) is the cyclic administration of high dose testosterone as a novel treatment for metastatic castration resistant prostate cancer (mCRPC). We hypothesized that rapid testosterone cycling would promote improvements in body composition and these would be associated with improvements in lipid profiles, and quality-of-life.</p><p></p><p>Methods: Men from two completed trials with CT imaging at baseline and after 3 cycles of BAT were included. Cross sectional areas of psoas muscle, visceral and subcutaneous fat were measured at the L3 vertebral levels. FACIT-Fatigue and Short Form-36 were used to measure quality of life.</p><p></p><p>Results: Participants (n=60) lost a mean of 7.8% of subcutaneous fat (SD 8.2%) and 9.8% of visceral fat (SD 18.2%) and gained 12.2% muscle mass (SD 6.7%). Changes in subcutaneous and visceral fat were positively correlated with each other (Spearman's correlation coefficient 0.58; 95% CI 0.35-0.71), independent of effects of age, body mass index, and duration of androgen deprivation therapy. Energy, physical function, and measures of limitations due to physical health were all significantly improved at 3-months. The improvements in body composition were not correlated with decreases in lipid levels or observed improvements in quality of life.</p><p></p><p>Conclusions: BAT is associated with significant improvements in body composition, lipid parameters, and quality of life. This has promising implications for the long-term health of men with mCRPC.</p><p></p><p>Ref: BJU Int. 2021 Mar 25. doi: 10.1111/bju.15408. Online ahead of print.</p></blockquote><p></p>
[QUOTE="Nelson Vergel, post: 199145, member: 3"] [B]Reversing the effects of androgen deprivation therapy in men with metastatic castration resistant prostate cancer[/B] Abstract Background: Bipolar androgen therapy (BAT) is the cyclic administration of high dose testosterone as a novel treatment for metastatic castration resistant prostate cancer (mCRPC). We hypothesized that rapid testosterone cycling would promote improvements in body composition and these would be associated with improvements in lipid profiles, and quality-of-life. Methods: Men from two completed trials with CT imaging at baseline and after 3 cycles of BAT were included. Cross sectional areas of psoas muscle, visceral and subcutaneous fat were measured at the L3 vertebral levels. FACIT-Fatigue and Short Form-36 were used to measure quality of life. Results: Participants (n=60) lost a mean of 7.8% of subcutaneous fat (SD 8.2%) and 9.8% of visceral fat (SD 18.2%) and gained 12.2% muscle mass (SD 6.7%). Changes in subcutaneous and visceral fat were positively correlated with each other (Spearman's correlation coefficient 0.58; 95% CI 0.35-0.71), independent of effects of age, body mass index, and duration of androgen deprivation therapy. Energy, physical function, and measures of limitations due to physical health were all significantly improved at 3-months. The improvements in body composition were not correlated with decreases in lipid levels or observed improvements in quality of life. Conclusions: BAT is associated with significant improvements in body composition, lipid parameters, and quality of life. This has promising implications for the long-term health of men with mCRPC. Ref: BJU Int. 2021 Mar 25. doi: 10.1111/bju.15408. Online ahead of print. [/QUOTE]
Insert quotes…
Verification
Post reply
Share this page
Facebook
Twitter
Reddit
Pinterest
Tumblr
WhatsApp
Email
Share
Link
Sponsors
Forums
Testosterone Replacement, Low T, HCG, & Beyond
Prostate Related Issues
How High Testosterone Doses Are Helping Men with Prostate Cancer
This site uses cookies to help personalise content, tailor your experience and to keep you logged in if you register.
By continuing to use this site, you are consenting to our use of cookies.
Accept
Learn more…
Top